Lexicon Pharmaceuticals, Inc. Alternatives & Competitors

12 companies similar to Lexicon Pharmaceuticals, Inc. — At Lexicon, We Pioneer Medicines that Transform Patients' Lives

Blueprint Medicines

Striving to improve and extend patients' lives

782 Acquired $11.61B

Cambridge, United States

Biotechnology Health Care +1

Compare

Apollomics

We are a biopharmaceutical company committed to the discovery and development of mono- and...

26 Post-IPO Equity $262.60M

Foster City, United State...

Biotechnology Health Care +1

Compare

Endocyte

16 Debt Financing $114.35M

West Lafayette, United St...

Biotechnology Health Care +1

ROME Therapeutics

Harnessing the power of the repeatome to develop a new class of therapies for cancer and a...

16 Acquired $199.00M

Boston, United States

Biotechnology Health Care +1

Rival Readout

Competing with Lexicon Pharmaceuticals, Inc.? We do this properly.

10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.

Book a 7-day Readout

Reviva Pharmaceuticals

Next Generation Therapeutics to successfully address central nervous system, metabolic and...

18 Post-IPO Equity

Cupertino, United States

Biopharma Biotechnology +2

Verseon

Game-Changing Technology, Life-Changing Medicines

22 $18.78M

Fremont, United States

Biotechnology Health and Wellness +1

Day One Biopharmaceuticals

Cancer drug development comes of age.

190 Post-IPO Equity $687.50M

Brisbane, United States

Biopharma Biotechnology +2

Heidelberg Pharma Research GmbH

37 Post-IPO Secondary $284.39M

Ladenburg, Germany

Biotechnology Health Care +1

PaxMedica, Inc.

Empowering Possibilities, Transforming Lives: PaxMedica's Journey in Neurodevelopmental So...

7 Post-IPO Equity $30.68M

Tarrytown, United States

Biotechnology Pharmaceutical

Novartis

Reimagining medicine by transforming cancer

84734 IPO $6.01B

Basel, Switzerland

Biotechnology Pharmaceutical

Santaris Pharma

Pioneering RNA-targeted therapies with rapid LNA-based drug development for diverse diseas...

Venture round $72.40M

Biotechnology Health Care +1

Forma Therapeutics

Dedicated to transforming the lives of patients with rare hematologic diseases and cancers...

159 Series D $142.50M

Watertown, United States

Biotechnology Health Care +1

About Lexicon Pharmaceuticals, Inc.

Lexicon Pharmaceuticals, Inc. is a biopharmaceutical company that has been pioneering the use of genetics in drug discovery since 1995. Their unique approach involves harnessing the power of the genome to identify potential drug targets and develop novel drug candidates in clinical development for a wide range of indic...

Business keywords

Biopharmaceutical, Genetics, Drug Discovery, Genomics, Clinical Development, Molecular Entities, Targeted Therapies, Gene Knockout Technology, Recombinant DNA, Chemistry Technologies, Diabetes, Carcinoid Syndrome, Clinical Trials, Patient-centric

Frequently Asked Questions

Companies similar to Lexicon Pharmaceuticals, Inc. include Blueprint Medicines, Apollomics, Endocyte, ROME Therapeutics, Reviva Pharmaceuticals. They work in Biotechnology and Pharmaceutical and share Lexicon Pharmaceuticals, Inc.'s focus on clinical trials, drug discovery and biopharmaceutical.

Bounce Watch lists 12 companies that share Lexicon Pharmaceuticals, Inc.'s industries and are closest to it in business tags, services, target customers, business model and size.

From the desk

Mapping a market? Start with a Rival Readout.

In 7 business days we read 10 rivals around Lexicon Pharmaceuticals, Inc.: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.

Book a 7-day Readout Get a free snapshot

Explore Related

Lexicon Pharmaceuticals, Inc. Profile Blueprint Medicines Alternatives Apollomics Alternatives Endocyte Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at Lexicon Pharmaceuticals, Inc. on 9 Jun 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 2 Sep 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.